In July 2024, the UK National Screening Committee (UK NSC) released an annual report from April 1, 2023 to March 31, 2024. The report provides a summary of the Committee’s ongoing work and accomplishments, including recommendations regarding the introduction of national population screening programs.

At the end of July 2024, the French Ministry of Health released a document on the RIHN reform process, including the description on the new RIHN application and evaluation process, but also how the HAS will evaluate tests currently covered in the RIHN Nomenclature, with the purpose of of deciding whether these tests will be granted permanent reimbursement, or will be excluded from coverage within the statutory health insurance. Cleaning the current AHN List will allow for the financing of truly innovative tests patients need.

On July 10, 2024, the Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) informed that the federal government, states, and sickness funds had defined their priorities for digitizing the healthcare system within the healthcare reform. The corresponding document, “eHealth Strategy Austria”, was presented on July 10, 2024, outlining the priorities up to 2030.

On July 30, 2024, NHS England announced the next steps in delegating commissioning responsibilities to local commissioners - integrated care boards (ICBs). NHS England plans to complete the delegation of all ‘suitable and ready’ specialized services (the 59 services already delegated in three regions, plus 11 other services) in all seven regions by April 2025

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in July 2024. Nine recommendations were published concerning the registration of medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular, neurovascular, interventional radiology, nephrology and urology, orthopedic, endocrine devices, and in-vitro diagnostic tests, as well as medical aids.

In July 2024, SBRI (Small Business Research Initiative) Healthcare launched new funding competitions in four priority areas: antimicrobial resistance, women’s health, urgent & emergency care, and stroke. All types of innovations are eligible, including but not limited to medical devices, in-vitro diagnostics, digital health, and AI solutions.

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 16951 of July 22, 2024, Tuscany Regional Healthcare published five new assessments and two reassessments of medical devices in the cardiovascular, peripheral vascular, surgical procedures, and obstetrics and gynecology areas.

In the second quarter of 2024, the Dutch Healthcare Institute (ZIN) published four coverage positions on proton therapy in testicular cancer, pulmonary artery pressure remote monitoring in chronic heart failure and neuromodulation in polyneuropathy with positive recommendation for coverage under basic insurance package, and on physiotherapy and exercise therapy in primary care settings for lower back pain, which was not recommended for coverage under the basic insurance package.

In the middle of July 2024, the new version of the classification of procedure codes (CCAM v.76) was published. Several changes were introduced, including creating 14 new codes in diagnostic imaging, men’s health, and neuromodulation technology groups.

On July 12, 2024, the UK National Screening Committee (UK NSC) announced a new task group for multi-cancer detection (MCD) tests. The group will review different methods for the evaluation of MCDs, from which UK NSC is expected to derive a position statement and develop a roadmap for a possible MCD screening program.

The new framework agreement on the medical devices included in the LPPR was signed on July 2, 2024.

On July 9, 2024, the updated Finnish classification of procedures (THL) was published to come into force on August 1, 2024. Forty-three new procedure codes were implemented concerning diagnostic imaging, nuclear medicine, neurovascular, radiology, and other fields.